DePaul Community Health Centers (DCHC) celebrated the unveiling of its artistic murals, created by world renowned visual ...

Hemophilia treatment market is driven by aging populations increasing acquired cases, government-backed early diagnosis, and ...

You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events ...

The FDA has approved Novartis’ Fabhalta (iptacopan) as the first and only treatment for C3 glomerulopathy (C3G). Previously, patients with C3G were forced to rely on supportive care and broad ...